DRUG:AU:AU-BetaShares Global Healthcare Currency Hedged (AUD)

ETF | Others |

Last Closing

USD 8.45

Change

0.00 (0.00)%

Market Cap

USD 0.17B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for Others

ETFs Containing DRUG:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.51% 94% A 74% C
Dividend Return 0.35% 11% F 7% C-
Total Return 7.85% 93% A 75% C
Trailing 12 Months  
Capital Gain -0.24% 13% F 51% F
Dividend Return 2.96% 41% F 35% F
Total Return 2.72% 13% F 51% F
Trailing 5 Years  
Capital Gain 34.55% 70% C- 71% C-
Dividend Return 11.65% 27% F 26% F
Total Return 46.21% 57% F 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 6.72% 64% D 54% F
Dividend Return 8.48% 63% D 53% F
Total Return 1.77% 57% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 8.51% 65% D 92% A
Risk Adjusted Return 99.63% 88% B+ 96% N/A
Market Capitalization 0.17B 33% F 65% D

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.